Center for Diabetes & Metabolic Diseases Pilot & Feasibility Grant: Category 3

Center for Diabetes & Metabolic Diseases Pilot & Feasibility Grant: Category 3

Status: ACTIVE
Funder: Indiana Clinical and Translational Sciences Institute (CTSI)
Amount: Up to US $50,000
Last Updated: January 08, 2026

Summary

The Center for Diabetes & Metabolic Diseases Pilot & Feasibility Grant offers funding up to $50,000 for innovative research projects aimed at diabetes and metabolic diseases. This program encourages early-career physician-scientists and established investigators to explore new ideas that diverge from their current research. The funding is intended to foster collaborations and support major grant submissions, making it an excellent opportunity for researchers at Indiana University and partner institutions.

Overview

Center for Diabetes & Metabolic Diseases Pilot & Feasibility Grant A primary research-related activity of the Center for Diabetes and Metabolic Diseases (CDMD)’s Pilot and Feasibility (P&F) program is to foster the development of new diabetes-related investigators and provide seed-support for innovative, high-risk projects. The CDMD P&F program has three different grant mechanisms: Parent P&F Grants: This mechanism invites applications directed towards basic biomedical, clinical, and/or translational research questions on cellular and molecular metabolism related to diabetes/obesity/metabolic syndrome, clinical and outcomes research in diabetes and obesity, complications of diabetes and obesity, islet function and survival, and nutrition and physiology of diabetes and obesity. Alzheimer’s-Focused P&F Grants: This mechanism invites applications focused on diabetes and metabolic disease aspects of Alzheimer’s disease and its related dementias (AD/ADRD)–frontotemporal dementia, Lewy body dementia, vascular cognitive impairment with dementia, and multiple etiology dementias. Physician-Scientist P&F Grants: This mechanism invites applications from exceptional emerging physician-scientists holding an MD (or equivalent) or MD/PhD with a patient-oriented diabetes and/or obesity-related clinical research project, who are early in their clinical research careers and show great promise to develop into future independent investigators. Category 3 Established investigators in diabetes who propose testing innovative ideas that represent clear departure from ongoing research interests Funding Awards are up to $50,000 for one year Travel budget requested must be limited to those expenses necessary to carry out the specific aims of the proposed project.Graduate student stipends (only) are an allowable expense. Publication fees are deemed an allowable expense.

Eligibility

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website. All eligible investigators must have faculty appointments, be independent investigators and have the education, skills, knowledge, and resources necessary to carry out the proposed research. These funding opportunities invite applications from investigators at Indiana University School of Medicine and other Indiana University campuses (IU Bloomington, IU Muncie, etc.), Purdue University, University of Notre Dame and the Indiana Biomedical Research Institute (IBRI).Work supported by these funds is expected to lead to submissions of major extramural grants (R01/equivalent NIH, major foundation awards, DOD, etc.)National and international collaborations are allowed.Note that established non-diabetes and diabetes-related investigators with previous and/or ongoing substantial NIH-supported independent research awards can submit applications pursuing high impact/high risk projects or projects that are a significant departure from their usual work.

Ineligibility

Postdoctoral fellows or their equivalent are not eligible.Travel to conferences or seminars are not an allowable expense.Budget requests may not include indirect costs, F&A, or PI salaries.